M&A Deal Summary |
|
|---|---|
| Date | 2020-06-29 |
| Target | Meridien Research |
| Sector | Life Science |
| Buyer(s) | Accel Research Sites |
| Sellers(s) | Avego Healthcare Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Medical Products |
Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. Accel Research Sites partners with innovative and significant pharmaceutical, biotechnology, and medical device companies in the world to advance healthcare and wellness in the communities it serves. Accel Research Sites was founded in 1998 and is based in Lake Mary, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
Avego Healthcare Capital is a private investment firm focused on investing in expansion stage healthcare companies. Avego has a special interest in companies that are commercializing and developing important therapeutics, medical products, and services for patients, physicians, and other customers in the US and globally. Avego Healthcare Capital was formed in 2015 and is based in Alpharetta, Georgia.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Life Science M&A | 1 of 4 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 1 of 4 |
| Year: 2020 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-16 |
Meridien Research
Winter Park, Florida, United States Meridien Research is a multi-specialty clinical research site company which conducts Phase I-IV inpatient and outpatient clinical trials for global, mid-sized pharmaceutical and biotech sponsors, as well as the largest contract research organizations (“CROs”). Meridien’s research covers more than 50 indications, with the range of therapeutic areas spanning central nervous system, mental health, neurology, metabolic and endocrine disorders and women’s health. Meridien Research was founded in 2000 and is based in Winter Park, Florida. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-16 |
Eyevance Pharmaceuticals
Fort Worth, Texas, United States Eyevance Pharmaceuticals is committed to developing and commercializing innovative and impactful ophthalmic products that enable optimal vision, better quality of life, and address significant unmet medical needs. Eyevance Pharmaceuticals was founded in 2017 and is based in Fort Worth, Texas. |
Sell | - |
